NEW YORK (GenomeWeb) – Synthetic promoter firm Synpromics announced today that it has completed a £5.2 million ($6.6 million) financing round.

Participants in the round included existing investors Calculus Capital, the Scottish Investment Bank, and private shareholders, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.